A detailed history of Crossmark Global Holdings, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 34,835 shares of EW stock, worth $2.58 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
34,835
Previous 41,452 15.96%
Holding current value
$2.58 Million
Previous $3.83 Million 39.96%
% of portfolio
0.04%
Previous 0.07%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$59.7 - $93.78 $395,034 - $620,542
-6,617 Reduced 15.96%
34,835 $2.3 Million
Q2 2024

Jul 29, 2024

SELL
$84.3 - $94.31 $6,996 - $7,827
-83 Reduced 0.2%
41,452 $3.83 Million
Q1 2024

May 13, 2024

SELL
$72.54 - $95.56 $235,392 - $310,092
-3,245 Reduced 7.25%
41,535 $3.97 Million
Q4 2023

Feb 13, 2024

SELL
$61.71 - $77.76 $215,676 - $271,771
-3,495 Reduced 7.24%
44,780 $3.42 Million
Q3 2023

Nov 08, 2023

BUY
$69.28 - $93.38 $35,402 - $47,717
511 Added 1.07%
48,275 $3.52 Million
Q2 2023

Jul 31, 2023

SELL
$81.41 - $94.33 $57,719 - $66,879
-709 Reduced 1.46%
47,764 $4 Million
Q1 2023

May 12, 2023

SELL
$74.26 - $84.51 $106,191 - $120,849
-1,430 Reduced 2.87%
48,473 $4.01 Million
Q4 2022

Jan 19, 2023

BUY
$68.3 - $87.44 $287,201 - $367,685
4,205 Added 9.2%
49,903 $3.72 Million
Q3 2022

Nov 01, 2022

SELL
$82.37 - $107.29 $25,452 - $33,152
-309 Reduced 0.67%
45,698 $3.78 Million
Q2 2022

Jul 29, 2022

SELL
$86.5 - $128.27 $1.52 Million - $2.26 Million
-17,594 Reduced 27.66%
46,007 $4.37 Million
Q1 2022

May 11, 2022

BUY
$101.96 - $128.34 $16,619 - $20,919
163 Added 0.26%
63,601 $7.49 Million
Q4 2021

Jan 10, 2022

SELL
$106.37 - $130.68 $122,644 - $150,674
-1,153 Reduced 1.79%
63,438 $8.22 Million
Q3 2021

Oct 21, 2021

BUY
$102.91 - $122.75 $3.12 Million - $3.72 Million
30,289 Added 88.3%
64,591 $7.31 Million
Q3 2021

Oct 13, 2021

SELL
$102.91 - $122.75 $3.91 Million - $4.66 Million
-37,983 Reduced 52.55%
34,302 $614,000
Q2 2021

Jul 21, 2021

SELL
$83.84 - $104.76 $130,035 - $162,482
-1,551 Reduced 2.1%
72,285 $7.49 Million
Q1 2021

Apr 15, 2021

SELL
$78.68 - $90.67 $68,687 - $79,154
-873 Reduced 1.17%
73,836 $6.18 Million
Q4 2020

Jan 14, 2021

SELL
$71.69 - $91.23 $661,698 - $842,052
-9,230 Reduced 11.0%
74,709 $6.82 Million
Q3 2020

Oct 08, 2020

BUY
$67.19 - $87.44 $14,580 - $18,974
217 Added 0.26%
83,939 $6.7 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $3.3 Million - $4.42 Million
57,395 Added 218.01%
83,722 $5.79 Million
Q1 2020

Apr 28, 2020

BUY
$52.41 - $81.0 $72,692 - $112,347
1,387 Added 5.56%
26,327 $1.66 Million
Q4 2019

Feb 06, 2020

SELL
$71.7 - $82.09 $65,820 - $75,358
-918 Reduced 3.55%
24,940 $5.82 Million
Q3 2019

Oct 09, 2019

BUY
$61.55 - $75.43 $429,926 - $526,878
6,985 Added 37.01%
25,858 $5.69 Million
Q2 2019

Jul 09, 2019

SELL
$55.74 - $64.41 $33,053 - $38,195
-593 Reduced 3.05%
18,873 $3.49 Million
Q1 2019

May 02, 2019

SELL
$47.89 - $64.05 $28,255 - $37,789
-590 Reduced 2.94%
19,466 $3.72 Million
Q4 2018

Jan 31, 2019

SELL
$46.41 - $56.94 $102,983 - $126,349
-2,219 Reduced 9.96%
20,056 $3.07 Million
Q3 2018

Nov 08, 2018

SELL
$45.7 - $58.03 $63,842 - $81,067
-1,397 Reduced 5.9%
22,275 $3.88 Million
Q2 2018

Jul 31, 2018

SELL
$42.45 - $51.3 $25,894 - $31,293
-610 Reduced 2.51%
23,672 $3.45 Million
Q1 2018

Apr 16, 2018

SELL
$37.19 - $47.45 $46,115 - $58,838
-1,240 Reduced 4.86%
24,282 $3.39 Million
Q4 2017

Feb 05, 2018

BUY
$33.79 - $39.39 $76,534 - $89,218
2,265 Added 9.74%
25,522 $2.88 Million
Q3 2016

Oct 25, 2017

BUY
N/A
23,257
23,257 $2.54 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.